Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hurler Syndrome
100%
Cord Blood Stem Cell Transplantation
100%
Pharmacokinetics
100%
Myeloablative Conditioning
100%
Busulfan
100%
Cyclophosphamide
50%
Conditioning
40%
Thymocyte Antibody
40%
Graft Failure
30%
Fludarabine
30%
Graft Versus Host Reaction
30%
Overall Survival
20%
Alemtuzumab
20%
Cumulative Incidence
10%
Vein Occlusion
10%
HLA Matching
10%
Keyphrases
Pharmacokinetics
100%
Hurler Syndrome
100%
Myeloablative Conditioning
100%
Busulfan
100%
Cord Blood Transplantation
100%
Cyclophosphamide
50%
Antithymocyte Globulin
40%
Fludarabine
30%
Graft Failure
30%
Graft-versus-host Disease (GvHD)
20%
Alemtuzumab
20%
Venous Disease
10%
Graft Outcome
10%
HLA Matching
10%
Confidence Interval
10%
Overall Survival
10%
Donor chimerism
10%
Cumulative Incidence
10%
5-year Survival
10%
Autologous Reconstitution
10%
Pharmacology, Toxicology and Pharmaceutical Science
Busulfan
100%
Hurler Syndrome
100%
Pharmacokinetics
100%
Cyclophosphamide
50%
Thymocyte Antibody
40%
Graft Versus Host Reaction
30%
Graft Failure
30%
Fludarabine
30%
Overall Survival
20%
Alemtuzumab
20%
Vein Occlusion
10%
Immunology and Microbiology
Cord Blood Stem Cell Transplantation
100%
Pharmacokinetics
100%
Conditioning
71%
Cyclophosphamide
71%
Anti-Thymocyte Globulin
57%
Graft-Versus-Host Disease
42%
Overall Survival
28%
Alemtuzumab
28%
HLA Matching
14%